LONDON - The European Commission has authorized the use of Vocabria and Rekambys, a long-acting injectable regimen, for adolescents living with HIV-1, ViiV Healthcare, majority-owned by GSK (NYSE: GSK ...
Laurus Labs stock declined by more than 15 per cent on Monday following the U.S. government’s directive to halt the President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback